A novel haemophilia treatment has passed its first regulatory stage in the UK.
Marstacimab is the first treatment of its kind, and works by targeting the protein TFPI which normally reduces blood clotting ability. It gained European Union approval...
9 months ago
Doctors have announced the discovery of a new sub-type of the rare immune disorder Castleman鈥檚 disease, opening the way for improved treatments.
The new subtype has been named oligocentric Castleman鈥檚 disease (OligoCD). According to the researcher...
9 months ago
